in last analysis, I'm only happy for lupus patients, not for some speculators, this benlysta isn't the breakthrough drug expected, but it may bring better condititons for patients. I would Wait for fda final approval, before laughing. Imho panel reccomendation was too forced...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.